DK
Daily Intelligence Brief· 60 sec read

Reimbursement is quietly widening — and the TBI evidence just got harder to ignore.

Five signals worth your attention today, distilled from 412 sources.

  1. 1

    CMS opens 60-day comment window on expanding HBOT reimbursement for late-effect radiation injury — potential material upside for wound-care programs.

  2. 2

    New Tel Aviv trial (n=319) shows sustained cognitive gains 12 months post-HBOT in mild TBI patients, strongest signal to date.

  3. 3

    Three multi-site clinics announced acquisitions this week; consolidation continues in the Southeast US.

  4. 4

    Google search interest for “HBOT autism” up 34% MoM; three influential podcasts cited HBOT protocols.

  5. 5

    Chamber manufacturer Sechrist releases updated 3300 model with quieter compressor and integrated telemetry.

Breakout Trends

Movements gaining velocity before mainstream coverage

Explore

Breaking

Live feed · ranked by estimated impact

All news
  • Research·Nature Neurology·2h ago94

    Sustained cognitive recovery 12 months after HBOT in mild TBI cohort

    Randomized crossover trial reports durable improvements in memory and executive function, with structural MRI changes correlating to clinical scores.

    Impact · Strengthens TBI referral case; useful for physician outreach decks.

  • Insurance·BCBS-NC Bulletin·4h ago88

    Blue Cross NC expands coverage for delayed radiation injury to HBOT

    Policy update adds coverage for soft tissue radionecrosis without prior surgical intervention requirement, effective Jan 1.

    Impact · Removes a common denial code — expect intake volume lift in NC.

  • Legislation·Texas Legislature·6h ago82

    Texas HB-2418 advances: veteran HBOT access pilot funded at $14M

    Committee approved bill funding a two-year veteran access pilot across five metros, with independent outcomes reporting.

    Impact · Opens veteran referral pipeline for accredited chambers in TX.

  • Technology·Sechrist Press·9h ago61

    Sechrist 3300 launches with integrated remote telemetry

    New monochamber reduces ambient noise 38% and streams pressure/temperature data to a supervising console.

    Impact · Relevant for capital planning cycles; watch trade-in incentives.

  • Business·Modern Healthcare·11h ago70

    Restore Hyperbarics acquires three Georgia clinics

    Consolidation continues in the Southeast, bringing Restore's network to 41 locations.

    Impact · Competitive pressure rising in GA metros; watch pricing shifts.

  • Clinical·UHMS·1d ago76

    UHMS releases updated indication guidance for chronic wound protocols

    Revised guidance clarifies session count expectations and documentation for reimbursement audits.

    Impact · Update charting templates before next audit cycle.

Clinical Trial Monitor

137 active HBOT trials · updated hourly from ClinicalTrials.gov

TrialStatusCompletion
HBOT vs sham in post-acute sequelae of COVID-19
NCT05821234 · Phase 3 · USA
RecruitingQ4 2026
Cognitive outcomes of HBOT in chronic mild TBI
NCT05719911 · Phase 2 · Israel
ActiveQ2 2026
Adjunct HBOT for diabetic foot ulcer healing
NCT05334220 · Phase 3 · UK
PublishedCompleted
HBOT protocol for radiation-induced cystitis
NCT05988712 · Phase 2 · USA
RecruitingQ1 2027
Pediatric HBOT for autism spectrum symptomatology
NCT05412018 · Phase 2 · Canada
ActiveQ3 2026

Industry Dashboard

Rolling snapshot of the HBOT market

Active US clinics
1,284+3.4%
Global market size
$4.9B+11.2% YoY
Avg. session price (self-pay)
$285+2.1%
Recruiting trials
137+9
Search interest (index)
168+18
Insurance approval rate
62%+1.8pp

Opportunity Radar

Where the market is quietly making room for your clinic

Research Feed

PubMed + curated journals · summarized in plain English

  • Nature Neurology·Efrati S, et al.·n = 319 4 min

    Neurocognitive gains persist 12 months post-HBOT in mild TBI

    Executive function and processing speed retained gains at 12mo follow-up.

    Strength of evidence88
  • JAMA Surgery·Chen L, Okafor N 6 min

    HBOT-driven angiogenesis in irradiated tissue: a mechanistic review

    Consolidates mechanism-of-action evidence for late radiation injury.

    Strength of evidence74
  • Lancet Rheumatology·Weiss P, et al.·n = 174 5 min

    Randomized trial of HBOT for fibromyalgia symptom burden

    Modest but statistically significant improvements in pain and sleep.

    Strength of evidence66

Legislative Tracker

Federal, state, and international policy affecting HBOT

  • US Federal·In committeeLow risk

    CMS proposed rule: radionecrosis reimbursement expansion

    60-day comment window; broadens covered indications for HBOT.

  • Texas·AdvancingLow risk

    TX HB-2418 — Veterans HBOT access pilot

    $14M funding for two-year access pilot across five metros.

  • Florida·IntroducedHigh risk

    FL SB-1129 — Off-label HBOT marketing restrictions

    Would limit off-label marketing claims; affects wellness clinics.